Incontinence & Overactive Bladder Health Center
This article is from the WebMD News Archive
Panel Recommends Curb in Episiotomy
Dec. 12, 2007 -- A routine procedure performed on up to 1 million American women per year may be needlessly contributing to incontinence in those women, an expert panel concluded Wednesday.
The procedure, known as episiotomy, involves cutting tissue between the lower vagina and the anus when women are in childbirth. While it is often used to aide delivery in cases of fetal distress or complicated childbirth, its use in routine births should be curtailed, the experts say.
"The routine use of this procedure should be seriously reconsidered," says C. Seth Landefeld, who led an expert consensus panel on fecal and urinary incontinence sponsored by the National Institutes of Health.
The procedure runs the risk of damaging the anal muscles, which in turn may cause up to 1,000 cases of fecal incontinence per year, says Katherine Hartmann, MD, PhD, deputy director of the Institute for Medicine and Public Health at Vanderbilt University Medical Center.
"It has a proven risk of damage," Hartmann says. "The connection is a pretty direct link."
Incontinence is the catch-all term for the involuntary loss of urine or stool. The risk of fecal and urinary incontinence increase with age; they are more common in women than men.
But both sexes are affected: It is estimated 5% of adults 65 to 74 and 20% of those over 85 experience fecal incontinence. One in five women and one in 20 men are estimated to suffer urinary incontinence by the time they're 45, according to the report.
(What are some of your most embarrassing incontinence moments? Share anonymously on WebMD's Women's Health: Friends Talking board.)
Incontinence Is Undertreated
While the problem is widespread, it is vastly undertreated, the panel warns.
"The shame, embarrassment, and stigma associated with these conditions pose significant barriers to seeking professional treatment, resulting in many persons who suffer from these conditions [going] without help," the report states.
In addition, most health plans don't pay doctors to do an independent evaluation for incontinence or counsel on weight loss, exercise, or specialized pelvic floor exercises that may help prevent it, says Landefeld, who directs the Center on Aging at the University of California, San Francisco.
And while articles in women's magazines often include suggestions for women to perform Kegel exercises to strengthen the pelvic floor muscles, experts say those exercises are frequently done incorrectly.
They urge more formal training for women to teach them how to isolate the pelvic floor muscles in a way that can be effective against urinary incontinence.
"Many women and men and many practitioners don't have a good idea of what the pelvic floor is," says Eileen Hoffman, MD, an associate professor of medicine at New York University. "You have muscles down there that if you don't have tone in [them], you're much more likely to have incontinence."
A high proportion of incontinence cases occur in nursing homes, according to the report. But instead of physical problems, many cases occur simply because elderly residents don't get to the bathroom in time.
The panel urged new policies that increase staffing at nursing homes so that residents don't sit, sometimes for hours, needing to use the toilet.
"That is probably more expensive then just letting them sit there in diapers," Landefeld says.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
ENABLEX is a prescription medicine used in adults to treat the following symptoms due to a condition called overactive bladder:
- · having a strong need to go to the bathroom right away (also called "urgency")
- · leaks or wetting accidents (also called "urinary incontinence")
- · having to go to the bathroom too often (also called "urinary frequency")
IMPORTANT SAFETY INFORMATION
You should not take once-daily ENABLEX if you have certain types of stomach problems, glaucoma, or have trouble emptying your bladder. Side effects of ENBLEX include blurred vision, and more commonly dry mouth, constipation, indigestion, and abdominal pain. Use caution when doing certain activities until you know how ENBALEX affects you.




